Buscar en
Clínica e Investigación en Arteriosclerosis
Toda la web
Inicio Clínica e Investigación en Arteriosclerosis La proteína desacoplante mitocondrial UCP3, ¿un nuevo actor en el metabolismo ...
Información de la revista
Vol. 15. Núm. 3.
Páginas 114-123 (Enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 15. Núm. 3.
Páginas 114-123 (Enero 2003)
Acceso a texto completo
La proteína desacoplante mitocondrial UCP3, ¿un nuevo actor en el metabolismo muscular de los ácidos grasos?
Visitas
...
F. Villarroya
Autor para correspondencia
gombau@porthos.bio.ub.es

Correspondencia: Departament de Bioquímica i Biologia Molecular.Universitat de Barcelona. Avda. Diagonal, 645. 08028 Barcelona. España.
Departament de Bioquímica i Biologia Molecular. Universitat de Barcelona. Barcelona. España
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
E. Ravussin, S. Lillioja, W.C. Knowler, L. Christin, D. Freymond, W.G. Abbott, et al.
Reduced rate of energy expenditure as a risk factor for body-weight gain.
N Engl J Med, 318 (1988), pp. 467-472
[2.]
S.B. Roberts, J. Savage, W.A. Coward, B. Chew, A. Lucas.
Energy expenditure and intake in infants born to lean and overweight mothers.
N Engl J Med, 318 (1988), pp. 461-466
[3.]
D.G. Nicholls, R.M. Locke.
Thermogenic mechanisms in brown fat.
Physiol Rev, 64 (1984), pp. 1-64
[4.]
J. Himms-Hagen, D. Ricquier.
Brown adipose tissue.
Handbook in obesity, pp. 415-441
[5.]
N.J. Rothwell, M.J. Stock.
A role for brown adipose tissue in diet-induced thermogenesis.
Nature, 281 (1979), pp. 31-35
[6.]
B.B. Lowell, V. Susulic, A. Hamann, J.A. Lawitts, J. Himms-Hagen, et al.
Development of obesity in transgenic mice after genetic ablation of brown adipose tissue.
Nature, 366 (1993), pp. 740-742
[7.]
G. Garruti, D. Ricquier.
Analysis of uncoupling protein and its ARNm in adipose tissue deposits of adult humans.
Int J Obes Relat Metab Disord, 16 (1992), pp. 383-390
[8.]
F. Bouillaud, F. Villarroya, E. Hentz, S. Raimbault, A.M. Cassard, D. Ricquier.
Detection of brown adipose tissue uncoupling proteinARNm in adult patients by human genomic probe.
Clin Sci, 75 (1988), pp. 21-27
[9.]
P. Huttunen, J. Hirvonen, V. Kinnula.
The occurrence of brown adipose tissue in outdoor workers.
Eur J Appl Physiol Occup Physiol, 46 (1981), pp. 339-345
[10.]
O. Champigny, D. Ricquier.
Evidence from in vitro differentiating cells that adrenoreceptor agonists can increase uncoupling protein ARNm level in adipocytes of adult humans.
J Lipid Res, 37 (1996), pp. 1907-1914
[11.]
H. Oberkofler, G. Dallinger, Y.M. Liu, E. Hell, F. Krempler, W. Patsch.
Uncoupling protein gene: quantification of expression levels in adipose tissues of obese and non-obese humans.
J Lipid Res, 38 (1997), pp. 2125-2133
[12.]
K. Clement, J. Ruiz, A.M. Cassard-Doulcier, F. Bouillaud, D. Ricquier, A. Basdevant, et al.
Additive effect of A ± G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3- adrenergic receptor gene on weight gain in morbid obesity.
Int J Obes Relat Metab Disord, 20 (1996), pp. 1062-1066
[13.]
J.M. Oppert, M.C. Vohl, M. Chagnon, F.T. Dionne, A.M. Cassard-Doulcier, D. Ricquier, et al.
DNA polymorphism in the uncoupling protein (UCP) gene and human body fat.
Int J Obes Relat Metab Disord, 18 (1994), pp. 526-531
[14.]
C. Fleury, M. Neverova, S. Collins, S. Raimbault, O. Champigny, C. Levi-Meyrueis, et al.
Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia.
Nat Genet, 15 (1997), pp. 269-272
[15.]
A. Vidal-Puig, G. Solanes, D. Grujic, J.S. Flier, B.B. Lowell.
UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue.
Biochem Biophys Res Commun, 235 (1997), pp. 79-82
[16.]
W. Mao, X.X. Yu, A. Zhong, W. Li, J. Brush, S.W. Sherwood, et al.
UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells.
FEBS Lett, 443 (1999), pp. 326-330
[17.]
R.K. Porter, M.D. Brand.
Body mass dependence of H+ leak in mitochondria and its relevance to metabolic rate.
Nature, 362 (1993), pp. 628-630
[18.]
D.W. Gong, Y. He, M. Karas, M. Reitman.
Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3- adrenergic agonists, and leptin.
J Biol Chem, 272 (1997), pp. 24129-24132
[19.]
O. Boss, S. Samec, A. Paoloni-Giacobino, C. Rossier, A. Dulloo, J. Seydoux, et al.
Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression.
FEBS Lett, 408 (1997), pp. 39-42
[20.]
S. Brun, M.C. Carmona, T. Mampel, O. Vinas, M. Giralt, R. Iglesias, et al.
Activators of peroxisome proliferator-activated receptor-alpha induce the expression of theuncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth.
Diabetes, 48 (1999), pp. 1217-1222
[21.]
S. Brun, M.C. Carmona, T. Mampel, O. Vinas, M. Giralt, R. Iglesias, et al.
Uncoupling protein-3 gene expression in skeletal muscle during development is regulated by nutritional factors that alter circulating non-esterified fatty acids.
FEBS Lett, 453 (1999), pp. 205-209
[22.]
O. Boss, S. Samec, F. Kuhne, P. Bijlenga, F. Assimacopoulos-Jeannet, J. Seydoux, et al.
Uncoupling protein-3 expression in rodent skeletal muscle is modulated by food intake but not by changes in environmental temperature.
J Biol Chem, 273 (1998), pp. 5-8
[23.]
N. Tsuboyama-Kasaoka, N. Tsunoda, K. Maruyama, M. Takahashi, H. Kim, S. Ikemoto, et al.
Up-regulation of uncoupling protein 3 (UCP3) ARNm by exercise training and down-regulation of UCP3 by denervation in skeletal muscles.
Biochem Biophys Res Commun, 247 (1998), pp. 498-503
[24.]
D. Kratky, J.G. Strauss, R. Zechner.
Tissue-specific activity of lipoprotein lipase in skeletal muscle regulates the expression of uncoupling protein 3 in transgenic mouse models.
Biochem J, 355 (2001), pp. 647-652
[25.]
S. Samec, J. Seydoux, A.G. Dulloo.
Skeletal muscle UCP3 and UCP2 gene expression in response to inhibition of free fatty acid flux through mitochondrial beta-oxidation.
Pflugers Arch, 438 (1999), pp. 452-457
[26.]
Y. Khalfallah, S. Fages, M. Laville, D. Langin, H. Vidal.
Regulation of uncoupling protein-2 and uncoupling protein-3 ARNm expression during lipid infusion in human skeletal muscle and subcutaneous adipose tissue.
Diabetes, 49 (2000), pp. 25-31
[27.]
O. Boss, E. Bobbioni-Harsch, F. Assimacopoulos-Jeannet, P. Muzzin, R. Munger, J.P. Giacobino, et al.
Uncoupling protein-3 expression in skeletal muscle and free fatty acids in obesity.
[28.]
A.K. Hihi, L. Michalik, W. Wahli.
PPARs: transcriptional effectors of fatty acids and their derivatives.
Cell Mol Life Sci, 59 (2002), pp. 790-798
[29.]
N. Pedraza, G. Solanes, M.C. Carmona, R. Iglesias, O. Vinas, T. Mampel, et al.
Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene.
Diabetes, 49 (2000), pp. 1224-1230
[30.]
Pedraza N, Solanes G, Giralt M, Villarroya F. Metabolic control of the uncoupling protein-3 (UCP3) gene expression in skeletal muscle. First International Symposium on PPARs. Giovanni Lorenzini Foundation, 2000
[31.]
C. Garcia-Martinez, B. Sibille, G. Solanes, C. Darimont, K. Mace, F. Villarroya, et al.
Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid vs. glucose oxidation.
Faseb J, 15 (2001), pp. 2033-2035
[32.]
J.C. Clapham, J.R. Arch, H. Chapman, A. Haynes, C. Lister, G.B. Moore, et al.
Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean.
Nature, 406 (2000), pp. 415-418
[33.]
S. Cadenas, K.S. Echtay, J.A. Harper, M.B. Jekabsons, J.A. Buckingham, E. Grau, et al.
The basal proton conductance of skeletal muscle mitochondria from transgenic mice overexpressing or lacking uncoupling protein-3.
J Biol Chem, 277 (2002), pp. 2773-2778
[34.]
A.J. Vidal-Puig, D. Grujic, C.Y. Zhang, T. Hagen, O. Boss, Y. Ido, et al.
Energy metabolism in uncoupling protein 3 gene knockout mice.
J Biol Chem, 275 (2000), pp. 16258-16266
[35.]
D.W. Gong, S. Monemdjou, O. Gavrilova, L.R. Leon, B. Marcus-Samuels, C.J. Chou, et al.
Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3.
J Biol Chem, 275 (2000), pp. 16251-16257
[36.]
V. Bezaire, W. Hofmann, J.K. Kramer, L.P. Kozak, M.E. Harper.
Effects of fasting on muscle mitochondrial energetics and fatty acid metabolism in Ucp3(-/-) and wild-type mice.
Am J Physiol Endocrinol Metab, 281 (2001), pp. E975-E982
[37.]
B. Sibille, C. Keriel, E. Fontaine, F. Catelloni, M. Rigoulet, X.M. Leverve.
Octanoate affects 2,4-dinitrophenol uncoupling in intact isolated rat hepatocytes.
Eur J Biochem, 231 (1995), pp. 498-502
[38.]
C. Pecqueur, E. Couplan, F. Bouillaud, D. Ricquier.
Genetic and physiological analysis of the role of uncoupling proteins in human energy homeostasis.
J Mol Med, 79 (2001), pp. 48-56
[39.]
P. Jezek, H. Engstova, M. Zackova, A.E. Vercesi, A.D. Costa, P. Arruda, et al.
Fatty acid cycling mechanism and mitochondrial uncoupling proteins.
Biochim Biophys Acta, 1365 (1998), pp. 319-327
[40.]
J. Himms-Hagen, M.E. Harper.
Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis.
Exp Biol Med, 226 (2001), pp. 78-84
[41.]
P. Schrauwen, W.H. Saris, M.K. Hesselink.
An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix.
Faseb J, 15 (2001), pp. 2497-2502
[41.]
G. Solanes, A. Vidal-Puig, D. Grujic, J.S. Flier, B.B. Lowell.
The human uncoupling protein-3 gene. Genomic structure, chromosomal localization, and genetic basis for short and long form transcripts.
J Biol Chem, 272 (1997), pp. 25433-25436
[42.]
P. Schrauwen, J. Xia, K. Walder, S. Snitker, E. Ravussin.
A novel polymorphism in the proximal UCP3 promoter region: effect on skeletal muscle UCP3 ARNm expression and obesity in male non-diabetic Pima Indians.
Int J Obes Relat Metab Disord, 23 (1999), pp. 1242-1245
[44.]
S. Otabe, K. Clement, C. Dina, V. Pelloux, B. Guy-Grand, P. Froguel, et al.
A genetic variation in the 5’ flanking region of the UCP3 gene is associated with body mass index in humans in interaction with physical activity.
Diabetologia, 43 (2000), pp. 245-249
[45.]
P.G. Cassell, P.J. Saker, S.J. Huxtable, E. Kousta, A.E. Jackson, A.T. Hattersley, et al.
Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin.
Diabetologia, 43 (2000), pp. 1558-1564
[46.]
D.J. Halsall, J. Luan, P. Saker, S. Huxtable, I.S. Farooqi, J. Keogh, et al.
Uncoupling protein 3 genetic variants in human obesity: the c-55t promoter polymorphism is negatively correlated with body mass index in a UK Caucasian population.
Int J Obes Relat Metab Disord, 25 (2001), pp. 472-477
[47.]
Y. Yanagisawa, K. Hasegawa, G.J. Dever, C.T. Otto, M. Sakuma, S. Shibata, et al.
Uncoupling protein 3 and peroxisome proliferatoractivated receptor gamma2 contribute to obesity and diabetes in palauans.
Biochem Biophys Res Commun, 281 (2001), pp. 772-778
[48.]
H. Shen, K. Xiang, W. Jia.
Effects of uncoupling protein 3 gene -55 C ± T variant on lipid metabolism, body fat, its distribution and non-insulin-dependent diabetes mellitus in Chinese.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 19 (2002), pp. 317-321
[49.]
S. Otabe, K. Clement, S. Dubois, F. Lepretre, V. Pelloux, R. Leibel, et al.
Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
Diabetes, 48 (1999), pp. 206-208
[50.]
O. Ukkola, A. Tremblay, G. Sun, Y.C. Chagnon, C. Bouchard.
Genetic variation at the uncoupling protein 1, 2 and 3 loci and the response to long-term overfeeding.
Eur J Clin Nutr, 55 (2001), pp. 1008-1015
[51.]
C.M. Lanouette, J.P. Giacobino, L. Perusse, M. Lacaille, C. Yvon, Y.C. Chagnon, et al.
Association between uncoupling protein 3 gene and obesity-related phenotypes in the Quebec Family Study.
Mol Med, 7 (2001), pp. 433-441
[52.]
C.M. Lanouette, Y.C. Chagnon, T. Rice, L. Perusse, P. Muzzin, J.P. Giacobino, et al.
Uncoupling protein 3 gene is associated with body composition changes with training in HERITAGE study.
J Appl Physiol, 92 (2002), pp. 1111-1118
[53.]
L.T. Dalgaard, T.L. Sorensen, T. Drivsholm, K. Borch-Johnsen, T. Andersen, T. Hansen, et al.
A prevalent polymorphism in the promoter of the UCP3 gene and its relationship to body mass index and long term weight change in the Danish population.
J Clin Endocrinol Metab, 86 (2001), pp. 1398-1402
[54.]
G. Argyropoulos, A.M. Brown, S.M. Willi, J. Zhu, Y. He, M. Reitman, et al.
Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes.
J Clin Invest, 102 (1998), pp. 1345-1351
[55.]
W.K. Chung, A. Luke, R.S. Cooper, C. Rotini, A. Vidal-Puig, M. Rosenbaum, et al.
Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis.
Diabetes, 48 (1999), pp. 1890-1895
[56.]
L. Nordfors, J. Hoffstedt, B. Nyberg, A. Thorne, P. Arner, M. Schalling, et al.
Reduced gene expression of UCP2 but not UCP3 in skeletal muscle of human obese subjects.
Diabetologia, 41 (1998), pp. 935-939
[57.]
L. Millet, H. Vidal, D. Larrouy, F. Andreelli, M. Laville, D. Langin.
ARNm expression of the long and short forms of uncoupling protein- 3 in obese and lean humans.
Diabetologia, 41 (1998), pp. 829-832
[58.]
A. Vidal-Puig, M. Rosenbaum, R.C. Considine, R.L. Leibel, G.L. Dohm, B.B. Lowell.
Effects of obesity and stable weight reduction on UCP2 and UCP3 gene expression in humans.
Obes Res, 7 (1999), pp. 133-140
[59.]
M.E. Harper, R. Dent, S. Monemdjou, V. Bezaire, L. Van Wyck, G. Wells, et al.
Decreased mitochondrial proton leak and reduced expression of uncoupling protein 3 in skeletal muscle of obese diet-resistant women.
Diabetes, 51 (2002), pp. 2459-2466
[60.]
P. Sbraccia, M. D’Adamo, F. Leonetti, A. Buongiorno, G. Silecchia, M.S. Basso, et al.
Relationship between plasma free fatty acids and uncoupling protein-3 gene expression in skeletal muscle of obese subjects: in vitro evidence of a causal link.
Clin Endocrinol, 57 (2002), pp. 199-207
[61.]
L.J. Mandarino, A. Consoli, A. Jain, D.E. Kelley.
Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
Am J Physiol, 270 (1996), pp. E463-E470
[62.]
A. Meirhaeghe, P. Amouyel, N. Helbecque, D. Cottel, S. Otabe, P. Froguel, et al.
An uncoupling protein 3 gene polymorphism associated with a lower risk of developing Type II diabetes and with atherogenic lipid profile in a French cohort.
Diabetologia, 43 (2000), pp. 1424-1428
[63.]
L.T. Dalgaard, T. Hansen, S.A. Urhammer, T. Drivsholm, K. Borch-Johnsen, O. Pedersen.
The uncoupling protein 3 -55 C ± T variant is not associated with Type II diabetes mellitus in Danish subjects.
Diabetologia, 44 (2001), pp. 1065-1067
[64.]
S. Bao, A. Kennedy, B. Wojciechowski, P. Wallace, E. Ganaway, W.T. Garvey.
Expression of ARNms encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes.
Diabetes, 47 (1998), pp. 1935-1940
[63.]
A. Krook, J. Digby, S. O’Rahilly, J.R. Zierath, H. Wallberg-Henriksson.
Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients.
Diabetes, 47 (1998), pp. 1528-1531
[66.]
H. Vidal, D. Langin, F. Andreelli, L. Millet, D. Larrouy, M. Laville.
Lack of skeletal muscle uncoupling protein 2 and 3 ARNm induction during fasting in type-2 diabetic subjects.
Am J Physiol, 277 (1999), pp. E830-E837
[67.]
P. Schrauwen, M.K. Hesselink, E.E. Blaak, L.B. Borghouts, G. Schaart, W.H. Saris, et al.
Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes.
Diabetes, 50 (2001), pp. 2870-2873
[68.]
H. Matsui, K. Okumura, K. Kawakami, M. Hibino, Y. Toki, T. Ito.
Improved insulin sensitivity by bezafibrate in rats: relationship tofatty acid composition of skeletal-muscletriglycerides.
Diabetes, 46 (1997), pp. 348-353
[69.]
J.L. Martindale, N.J. Holbrook.
Cellular response to oxidative stress: signaling for suicide and survival.
J Cell Physiol, 192 (2002), pp. 1-15
[70.]
V.P. Skulachev.
Uncoupling: new approaches to an old problem of bioenergetics.
Biochim Biophys Acta, 1363 (1998), pp. 100-124
[71.]
K.S. Echtay, D. Roussel, J. St-Pierre, M.B. Jekabsons, S. Cadenas, J.A. Stuart, et al.
Superoxide activates mitochondrial uncoupling proteins.
Nature, 415 (2002), pp. 96-99
[72.]
L.L. Listenberger, D.S. Ory, J.E. Schaffer.
Palmitate-induced apoptosis can occur through a ceramide-independent pathway.
J Biol Chem, 276 (2001), pp. 14890-14895
[73.]
D.L. Hickson-Bick, G.C. Sparagna, L.M. Buja, J.B. McMillin.
Palmitateinduced apoptosis in neonatal cardiomyocytes is not dependent on the generation of ROS.
Am J Physiol Heart Circ Physiol, 282 (2002), pp. H656-H664
[74.]
C. Duval, N. Auge, M.F. Frisach, L. Casteilla, R. Salvayre, A. Negre-Salvayre.
Mitochondrial oxidative stress is modulated by oleic acid via an epidermal growth factor receptor-dependent activation of glutathione peroxidase.
Biochem J, 367 (2002), pp. 889-894
[75.]
M.J. Barbera, A. Schluter, N. Pedraza, R. Iglesias, F. Villarroya, M. Giralt.
Peroxisome proliferator-activated receptor alpha activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell.
J Biol Chem, 276 (2001), pp. 1486-1493
Copyright © 2003. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos